Sign in
4

Changes in Ownership

Vistagen Therapeutics, Inc. Filed Acc 0001998663-26-000006

Options or other derivatives

  • Chief Operating Officer acquired 75,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Prince Joshua S. · Chief Operating Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-04-07 Grant or award : show line 1 in the form Incentive Stock Option (right to buy) +18,752 18,752 D
2026-04-07 Grant or award : show line 2 in the form Non-Qualified Stock Option (right to buy) +56,248 56,248 D
Loading xslF345X06/edgardoc.xml…